Volume 23, Issue 3 pp. 331-334

Familial factors in diabetic nephropathy: an offspring study

E. Agius

E. Agius

Diabetes Centre, St. Luke's Hospital, Guardamangia, Malta,

Search for more papers by this author
G. Attard

G. Attard

Diabetes Centre, St. Luke's Hospital, Guardamangia, Malta,

Search for more papers by this author
L. Shakespeare

L. Shakespeare

The Regional Endocrine Laboratory, University Hospital Birmingham, Birmingham,

Search for more papers by this author
P. Clark

P. Clark

The Regional Endocrine Laboratory, University Hospital Birmingham, Birmingham,

Search for more papers by this author
M.-A. Vidya

M.-A. Vidya

Adipokines and Metabolism Research Group, Centre for Clinical Pharmacology, University College London, London and

Search for more papers by this author
A. T. Hattersley

A. T. Hattersley

Centre of Molecular Genetics, Institute of Clinical Science, University of Exeter, Exeter, UK

Search for more papers by this author
S. Fava

S. Fava

Diabetes Centre, St. Luke's Hospital, Guardamangia, Malta,

Centre of Molecular Genetics, Institute of Clinical Science, University of Exeter, Exeter, UK

Search for more papers by this author
First published: 16 February 2006
Citations: 24
: Dr Stephen Fava, Diabetes Centre, St. Luke's Hospital, Guardamangia MSD07, Malta. E-mail: [email protected]

Abstract

Aims  Familial clustering of diabetic nephropathy in patients with Type 2 diabetes suggests that inherited factors predispose to diabetic nephropathy, but the nature of these factors is uncertain. The aim of the study was to compare the prevalence of known risk factors for nephropathy in non-diabetic offspring of Type 2 diabetic patients with and without nephropathy and in control subjects.

Methods  Three groups of patients were recruited with 40 or 41 subjects in each group. These were subjects having one Type 2 diabetic parent with nephropathy (DN); subjects having one parent with Type 2 diabetes without nephropathy (DnoN), and non-diabetic unrelated control subjects with no personal or parental history of diabetes (Control subjects).

Results  The median (interquartile range) albumin/creatinine ratio (ACR) was 1.40 (0.96–2.90) mg/mmol in DN; 0.94 (0.50–1.46) mg/mmol in DnoN and 1.22 (0.66–1.83) mg/mmol in Controls (anova: P = 0.03). ACR was higher in group DN than in DnoN (P < 0.006) and in Control subjects (P < 0.03), but there was no difference between DnoN and Control subjects. Twenty-four-hour ambulatory blood pressure monitoring showed mean daytime systolic blood pressure to be significantly higher in group DN than in DnoN (P < 0.02) or Control subjects (P < 0.01) (anova: P = 0.004). Fasting insulin, HOMA-IR, interleukin-6 (IL-6) and C-reactive protein (CRP) were similar in the three groups.

Conclusion  Our data provide further evidence that genetic factors are important in determining urinary albumin excretion and renal disease associated with Type 2 diabetes and suggest that genes that affect systemic arterial blood pressure but not those relating to insulin resistance or inflammation are likely to be implicated.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.